Our Newsletter


Categories


Bookmark and Share

AOR Advanced Biotics - 90 vcaps

Click to enlarge

Price:
CAD$ 38.88 (excluding tax)
SKU:
AOR04146
Weight:
0.10 KGS
Rating:
( )
Availability:
Usually shipped within 1-2 days
Shipping:
Calculated at checkout
Quantity:


Add to Wish List

Click the button below to add the AOR Advanced Biotics - 90 vcaps to your wish list.

Product Description

Probiotics are live microorganisms that promote a balanced intestinal microflora and a healthy gastrointestinal tract. AOR's Advanced BioticsTM formula contains a blend of seven clinically tested probiotic strains that possess antimicrobial, immunomodulatory, anticarcinogenic, antidiarrheal and antiallergenic properties.
Size: 90 Vegi-Caps
Weight: 368 mg
Code: AOR04146
100% VEGETARIAN


SUPPLEMENT FACTS:
Serving Size: 1 Capsule


Bifidobacterium Longum BB536 50mg (4,000,000,000 Organisms/Organismes)

Streptococcus Thermophilus

25mg (2,500,000,000 Organisms/Organismes)
Lactobacillus Acidophilus R-52 25mg (3,750,000,000 Organisms/Organismes)
Lactobacillus Rhamnosus R-11 25mg (3,750,000,000 Organisms/Organismes)
Lactobacillus Casei R-215 25mg (2,500,000,000 Organisms/Organismes)
Lactobacillus Gasseri LAC-343 12.5mg (625,000,000 Organisms/Organismes)
Lactobacillus Plantarum R-1012 25mg (3,750,000,000 Organisms/Organismes)
Inulin 180mg

Non-medicinal ingredients: glucose, fructose, sucrose, ascorbyl palmitate, maltodextrin, ascorbic acid. Capsule: hypromellose, sorbitol, silicon dioxide, water.

AOR guarantees that no ingredients not listed on the label have been added to the product. Contains no wheat, gluten, nuts, eggs, fish, or shellfish.

Suggested Use
Take one or two capsules three times a day without food.

• STORE IN A COOL, DRY PLACE; REFRIGERATE AFTER OPENING •

Main Applications
• Diarrhea
• Yeast infection
• Irritable bowel syndrome
• Inflammatory bowel disease
• Antibiotic related diarrhea
• Autoimmune diseases
• Atopic dermatitis
• Allergies

Source
Biological fermentation.

Pregnancy / Nursing
None.

Cautions
None.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.



Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink.
European Journal of Clinical Nutrition (2008) 62, 299–301.
Wenus C, Goll R, Loken EB, Biong AS, Halvorsen DS and Florholmen J.

OBJECTIVE: To study the preventive effect of a milk drink fermented with multistrain probiotics on antibiotic associated diarrhoea (AAD). DESIGN: Double-blind placebo controlled study. SETTING: University Hospital of North Norway. SUBJECTS AND METHODS: Of 853 patients treated with antibiotics, 87 met the inclusion criteria, and were randomized to ingestion of a fermented milk drink containing LGG, La-5 and Bb-12 (n=46) or placebo with heat-killed bacteria (n=41), during a period of 14 days. A diary was recorded, and stool samples were collected for microbiological analyses. RESULTS: Sixty-three patients completed the study according to the protocol; two patients (5.9%) in the treatment group and eight (27.6%) in the placebo group developed AAD (P=0.035). The relative risk of developing AAD was 0.21 (95% confidence interval: 0.05–0.93) when given probiotic milk drink. CONCLUSION: A fermented multistrain probiotic milk drink may prevent four of five cases of AAD in adult hospitalized patients.

Diet and chronic constipation. Benefits of oral supplementation with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight).
Acta Biomed. 2006 Dec;77(3):157-62.
Amenta M, Cascio MT, Di Fiore P, Venturini I.


BACKGROUND AND AIM: Constipation is one of the most common disorders in Western countries and it is known that dietary factors such as a low fiber diet and low caloric intake are associated with this condition. Weight loss can disrupt the intestinal ecosystem resulting in intestinal dysbiosis that worsens constipation. The aim of this study was to evaluate the effects of treatment with symbiotic zir fos (Bifidobacterium longum W11 + FOS Actilight) on chronic constipation in patients undergoing a weight loss diet. METHODS: Our evaluation included the recording of age, gender, weight, height, BMI, physical activity, constipation, diet, therapy compliance and laxative supplies. A hypocaloric diet (1,200/1,400 cal.) was prescribed to all patients, and they were submitted to a physical activity program and received 1 bag of symbiotic zir fos per day for the entire duration of the study. Patients' follow-up was available for up to 60 days. RESULTS: Two hundred and ninety seven patients (79.4% women and 18.2% men, mean age 32.2) were included in the study. The mean baseline BMI was 33.4 +/- 5.6 (range 22.8-56.3 Kg). The improvement of constipation turned out to be associated to age (p < 0.01). Patients with a mean age of 35 +/- 12 showed an improvement of constipation. BMI values were not significantly different among the groups of patients with improved, worsened or unchanged constipation. No significative difference was observed among groups due to physical activity. At the follow-up, after 20 days from the beginning of the study, patients that assumed at least 17/20 of the zir fos bags showed a greater improvement of constipation (p < 0.01) than the remaining patients who assumed less than 17/20 of the zir fos bags or that didn't assumed any at all. Patients that assumed laxatives (at least once a week) showedn to be more frequently associated with a worsening of constipation (p < 0.001). Diet compliance does not seem to influence the course of constipation. CONCLUSION: Our data demonstrate the utility of symbiotics in improving constipation during hypocaloric diet in the treatment of obesity.

Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors.
Nature Medicine. 2007 Jan;14(1):35-37.
Rousseaux C, Thuru1 X, Gelot A, Barnich N, Neut1 C, Dubuquoy1 L, Dubuquoy C, Merour1 E, Geboes K, Chamaillard M, Ouwehand A, Leyer G, Carcano D, Colombel1 JF, Ardid D & Desreumaux P.


Abdominal pain is common in the general population and, in patients with irritable bowel syndrome, is attributed to visceral hypersensitivity. We found that oral administration of specific Lactobacillus strains induced the expression of l-opioid and cannabinoid receptors in intestinal epithelial cells, and mediated analgesic functions in the gut—similar to the effects of morphine. These results suggest that the microbiology of the intestinal tract influences our visceral perception, and suggest new approaches for the treament of abdominal pain and irritable bowel syndrome.



Probiotics are live microorganisms that promote a balanced intestinal microflora and a healthy gastrointestinal tract. AOR's Advanced BioticsTM formula contains a blend of seven clinically tested probiotic strains that possess antimicrobial, immunomodulatory, anticarcinogenic, antidiarrheal and antiallergenic properties.
Streptocossus thermophilus
Frequently used as a starter culture in the production of yogurt, fermented milk and cheese, S. thermophilus is also a powerful probiotic. The bacterium has been isolated from human feces after oral consumption suggesting that it can survive transit through the gastrointestinal tract. Recent studies show that the bacterium survives the presence of bile salts and absorbs cholesterol, lowering total cholesterol - absorbing more LDL than HDL cholesterol and therefore advantageously targeting the «bad cholesterol». In animal trials, S.Thermophilus positively affected intestinal function and offered protection against enteroinvasive E.Coli, a pathogenic bacteria. This effect was mediated through the enhancement of the intestinal mucosal immunity.

Bifilon-50T
This bifidobacterium has been shown to reduce the symptoms and disturbances associated with seasonal allergies in Japan, normalized the immune system and prevented antigen-induced Th2 immune responses in animal studies. The Th2 immune response is mediated by antibodies and is associated with allergies. Studies have also demonstrated that the bacterium prevents DNA damage induced by heterocyclic aromatic amines (HCA) present in food such as beef mix and barbecued meats. This may explain the reduced colon cancer rates seen in individuals with high lactobacillus counts and high lactobacillus consumption.

L. Acidophilus R-52
This strain of probiotics used in conjunction with the L-Rhamnosus R-11 strain reduced bacterial colonization and gastric inflammation in mice infected with H. pylori. In animals subjected to chronic stress, it was found that the same two bacteria prevent intestinal abnormalities such as bacterial invasiveness and translocation to lymph nodes. Given with S. Thermophilus, the bacteria enhanced the immune response and the weight of the colon in animal that underwent intestinal surgery. The bacterium is a common and naturally present bacteria in the vaginal. Recent studies confirm that L. acidophilus R-52, L. helveticus and L. suntoryeus are synonymous.

L. Rhamnosus R-11
In a study conducted at Acadia University in Nova Scotia, this strain of bacteria was shown to have the most extensive effects on cytokine production in human intestinal mucosal cell lines. It was concluded that the L. Rhamnosus bacteria had the potential to influence the immune response to pathogens and other antigens through its profound impact on the mucosal environment.

L. Casei R-215
This lactic acid producing bacteria is known for its ability to colonize the gastrointestinal tract. Studies have shown that supplementation reduces the colonization of the gastrointestinal tract by Candida species and other pathogens.

L. Gasseri
Also shown to survive transit through the gastrointestinal tract, this species of lactobacillus possesses immunomodulatory effects. A randomized, double-blind, placebo-controlled human clinical trial using L. gasseri and L. coryniformis showed that the probiotic combo increased the proportion of phagocytic cells such as monocytes and neutrophils, two types of white blood cells. The probiotics also increase the proportion of natural killer cells and IgA concentrations and improved intestinal habits in healthy adults. This effect was seen after two weeks of treatment but was greater after 4 weeks of supplementation. In animals, L. gasseri reduced the growth of pathogenic bacteria such as Staphylococcus aureus.

In a study of 531 females, L. gasseri was one of three prevalent lactobacilli colonizing the rectum of 290 females. The study concluded that the presence of lactobacillus species in the rectum contributed to the maintenance of the vaginal microflora and decreased the risk of bacterial vaginosis. The presence of hydrogen peroxide producing lactobacilli probiotics in the vagina protects women against infections which lead to the production of proinflammatory molecules that are significant to the etiology of preterm birth.

L. Plantarum R-1012
Studies show that some strains of L. Plantarum bacteria prevent the adhesion of intestinal pathogens, making the bacteria a promising candidate for probiotic supplementation. Other studies demonstrate that the bacterium lowers cholesterol levels, but most importantly, L. Plantarum helps to balance the immune system and improves the Th1:Th2 ratio in healthy adults.

The health benefits associated with probiotic supplementation continue to surface. We all know that the wrong bacteria or the presence of bacteria in places where they should be absent can make us sick. However, we must realize that the right bacteria are essential to our health. It has been shown that there are more bacteria in our intestines than there are cells in our body. It stands to reason that having a healthy gastrointestinal microflora is essential to health. It should come as no surprise that the latest research shows that probiotics can help to mobilize and normalize the immune system, can prevent DNA damage thereby reducing cancer rates, prevents infections, reduces the incidence of diarrhea associated with the use of antibiotics, reduce cholesterol levels, and of course improves intestinal habits in healthy adults. 

References

Dilmi-Bouras A. Assimilation (in vitro) of cholesterol by yogurt bacteria. Ann Agric Environ Med. 2006;13(1):49-53.

Elli M, Callegari ML, Ferrari S, Bessi E, Cattivelli D, Soldi S, Morelli L, Goupil Feuillerat N, Antoine JM. Survival of yogurt bacteria in the human gut. Appl Environ Microbiol. 2006 Jul;72(7):5113-7.

Heyman M, Terpend K, Menard S. Effects of specific lactic acid bacteria on the intestinal permeability to macromolecules and the inflammatory condition. Acta Paediatr Suppl. 2005 Oct;94(449):34-6.

Xiao JZ, Kondo S, Yanagisawa N, Miyaji K, Enomoto K, Sakoda T, Iwatsuki K, Enomoto T. Clinical Efficacy of Probiotic Bifidobacterium longum for the Treatment of Symptoms of Japanese Cedar Pollen Allergy in Subjects Evaluated in an Environmental Exposure Unit. Allergol Int. 2007 Mar;56(1):67-75. Epub 2007 Jan 29.

Takahashi N, Kitazawa H, Iwabuchi N, Xiao JZ, Miyaji K, Iwatsuki K, Saito T. Oral administration of an immunostimulatory DNA sequence from Bifidobacterium longum improves Th1/Th2 balance in a murine model. Biosci Biotechnol Biochem. 2006 Aug;70(8):2013-7.

Zsivkovits M, Fekadu K, Sontag G, Nabinger U, Huber WW, Kundi M, Chakraborty A, Foissy H, Knasmuller S. Prevention of heterocyclic amine-induced DNA damage in colon and liver of rats by different lactobacillus strains. Carcinogenesis. 2003 Dec;24(12):1913-8.

Naser SM, Hagen KE, Vancanneyt M, Cleenwerck I, Swings J, Tompkins TA. Lactobacillus suntoryeus Cachat and Priest 2005 is a later synonym of Lactobacillus helveticus (Orla-Jensen 1919) Bergey et al. 1925 (Approved Lists 1980). Int J Syst Evol Microbiol. 2006 Feb;56(Pt 2):355-60.

Zareie M, Johnson-Henry K, Jury J, Yang PC, Ngan BY, McKay DM, Soderholm JD, Perdue MH, Sherman PM. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut. 2006 Nov;55(11):1553-60.

Wallace TD, Bradley S, Buckley ND, Green-Johnson JM. Interactions of lactic acid bacteria with human intestinal epithelial cells: effects on cytokine production. J Food Prot. 2003 Mar;66(3):466-72.

Manzoni P, Mostert M, Leonessa ML, Priolo C, Farina D, Monetti C, Latino MA, Gomirato G. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis. 2006 Jun 15;42(12):1735-42.

Olivares M, Diaz-Ropero MP, Gomez N, Lara-Villoslada F, Sierra S, Maldonado JA, Martin R, Rodriguez JM, Xaus J. The consumption of two new probiotic strains, Lactobacillus gasseri CECT 5714 and Lactobacillus coryniformis CECT 5711, boosts the immune system of healthy humans. Int Microbiol. 2006 Mar;9(1):47-52.

Antonio MA, Rabe LK, Hillier SL. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis. 2005 Aug 1;192(3):394-8.

Nguyen TD, Kang JH, Lee MS. Characterization of Lactobacillus plantarum PH04, a potential probiotic bacterium with cholesterol-lowering effects. Int J Food Microbiol. 2007 Feb 15;113(3):358-61.

Hirose Y, Murosaki S, Yamamoto Y, Yoshikai Y, Tsuru T. Daily intake of heat-killed Lactobacillus plantarum L-137 augments acquired immunity in healthy adults. J Nutr. 2006 Dec;136(12):3069-73.


Write your own product review

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product!

Recent News







Discounts, Wholesale, Buy

Buy This Item

Click the button below to add the AOR Advanced Biotics - 90 vcaps to your shopping cart for CAD$ 38.88.

Quantity:

Buy in bulk and save

Your Shopping Cart


You just added this product to your cart:

Other Products in Your Shopping Cart:


Shipping:
Handling:
Subtotal: CAD$ 0.00

View your entire cart

You Recently Viewed...